CHU Clermont Ferrand - Hôpital d'Estaing

Clermont-Ferrand, Puy De Dome 63003

1 studies enrolling now · 3 studies all time

What they study most

Relapsing-Remitting Multiple Sclerosis, Ulcerative Colitis

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Recruiting now
• Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed